7wireVentures January 8, 2025

Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment

Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’

Accolade shareholders to receive $7.03 per share in cash

San Francisco, CA and Seattle, WA January 8, 2025 – Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total equity value of approximately...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Insurance, Mergers & Acquisitions / JV, Provider, Self-insured, Technology, Trends
Related Articles:
From MSSP ACOs to Employer Value: Translating Value-Based Principles to Self-Insured Plans
Legal Issues in Value-Based Care Contracts for Self-Insured Employers
Restoring Affordability to Employer Health Plans
Carrum Health Expands SUD Treatment Program to Include Nearly All Substances
Healthcare Benefit Trends Report: Employers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions

Share Article